FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?

Publication date: Available online 4 June 2021Source: The LancetAuthor(s): Tazeen H Jafar

Source: The Lancet - June 5, 2021 Category: General Medicine Source Type: research